Drug development in the sharing economy

Submitted by Carlyn Zwarenstein on June 23, 2014 - 13:55

Sharing—what a concept. With scientific research tending in two directions—on one hand, towards more proprietary knowledge and more expensive and limited access, and on the other, towards open data and open access publications—it is interesting to note a new private-public partnership based in Toronto and New York that will provide completely open access to anyone who wants to use its structural genomics data. Is this what real sharing of information should look like?